2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?

Ahmed, A., Jorna, T., & Bhandari, S. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000447068 · Cited by 11,782

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

(2002) · The Lancet · doi:10.1016/s0140-6736(02)11911-8 · Cited by 10,266

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

(1998) · The Lancet · doi:10.1016/s0140-6736(98)07037-8 · Cited by 8,247

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Neal, B., Perkovic, V., Mahaffey, K. W., de Zeeuw, D., Fulcher, G., Erondu, N., Shaw, W., Law, G., Desai, M., & Matthews, D. R. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611925 · Cited by 7,830

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F. E., Nauck, M. A., Nissen, S. E., Pocock, S., Poulter, N. R., Ravn, L. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603827 · Cited by 7,629

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616

2020 International Society of Hypertension Global Hypertension Practice Guidelines

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132

The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

Vogel, B., Mónica Acevedo, B., Appelman, Y., Merz, C. N. B., Chieffo, A., Figtree, G. A., Guerrero, M. E., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,587

2020 International Society of Hypertension global hypertension practice guidelines

Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283

KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

Cheung, A. K., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Ix, J. H., Knoll, G. A., Muntner, P., Pecoits-Filho, R., Sarnak, M. J., et al. (2021) · Kidney International · doi:10.1016/j.kint.2020.11.003 · Cited by 1,452

Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023

Stark, B. A., DeCleene, N. K., Desai, E. C., Hsu, J. M., Johnson, C. O., Lara-Castor, L., LeGrand, K. E., Prof Bhoomadevi, A., Aalipour, M. A., Aalruz, H., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.08.015 · Cited by 900

The ARIC (Atherosclerosis Risk In Communities) Study

Wright, J. D., Folsom, A. R., Coresh, J., Sharrett, A. R., Couper, D. J., Wagenknecht, L. E., Mosley, T. H., Ballantyne, C. M., Boerwinkle, E., Rosamond, W. D., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.035 · Cited by 588

Spontaneous Coronary Artery Dissection

Hayes, S. N., Tweet, M. S., Adlam, D., Kim, E., Gulati, R., Price, J., & Rose, C. H. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.084 · Cited by 557

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

Grinspoon, S. K., Fitch, K. V., Zanni, M. V., Fichtenbaum, C. J., Umbleja, T., Aberg, J. A., Overton, E. T., Malvestutto, C., Bloomfield, G. S., Currier, J. S., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2304146 · Cited by 532

The global epidemics of diabetes in the 21st century: Current situation and perspectives

Standl, E., Khunti, K., Hansen, T. B., & Schnell, O. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319881021 · Cited by 515

Cardiovascular risk of smoking and benefits of smoking cessation

Gallucci, G., Tartarone, A., Lerose, R., Lalinga, A. V., & Capobianco, A. M. L. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.02.47 · Cited by 497

Statistical significance: p value, 0.05 threshold, and applications to radiomics—reasons for a conservative approach

Leo, G. D., & Sardanelli, F. (2020) · European Radiology Experimental · doi:10.1186/s41747-020-0145-y · Cited by 555

Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention

Osibogun, O., Ogunmoroti, O., & Michos, E. D. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.08.010 · Cited by 423

Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019

Précoma, D. B., de Oliveira, G. M. M., Simão, A. F. L., Dutra, Ó. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R., Giuliano, I. D. C. B., Filho, A. C. D. A., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 507

Interpretable prediction of 3-year all-cause mortality in patients with heart failure caused by coronary heart disease based on machine learning and SHAP

Wang, K., Tian, J., Zheng, C., Yang, H., Ren, J., Liu, Y., Han, Q., & Zhang, Y. (2021) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2021.104813 · Cited by 361

Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

Michos, E. D., McEvoy, J. W., & Blumenthal, R. S. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1806939 · Cited by 354

Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease

Liberale, L., Montecucco, F., Tardif, J., Libby, P., & Camici, G. G. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz961 · Cited by 363

Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women

Cho, L., Davis, M. B., Elgendy, I. Y., Epps, K., Lindley, K. J., Mehta, P. K., Michos, E. D., Minissian, M., Pepine, C. J., Vaccarino, V., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.060 · Cited by 363

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice

Koschinsky, M. L., Bajaj, A., Boffa, M. B., Dixon, D. L., Ferdinand, K. C., Gidding, S. S., Gill, E. A., Jacobson, T. A., Michos, E. D., Safarova, M. S., et al. (2024) · Journal of clinical lipidology · doi:10.1016/j.jacl.2024.03.001 · Cited by 360

2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia

Virani, S. S., Morris, P. B., Agarwala, A., Ballantyne, C. M., Birtcher, K. K., Kris-Etherton, P. M., Ladden-Stirling, A. B., Miller, M., Orringer, C. E., & Stone, N. J. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.06.011 · Cited by 341

Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia

Borén, J., Taskinen, M.-R., Björnson, E., & Packard, C. J. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00676-y · Cited by 315

Nutrition and behavioral health disorders: depression and anxiety

Kris‐Etherton, P. M., Petersen, K. S., Hibbeln, J. R., Hurley, D. L., Kolick, V., Peoples, S., Rodriguez, N. R., & Woodward-Lopez, G. M. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa025 · Cited by 342

Insights into Systemic Disease through Retinal Imaging-Based Oculomics

Wagner, S. K., Fu, D. J., Faes, L., Liu, X., Huemer, J. C., Khalid, H., Ferraz, D., Korot, E., Kelly, C. J., Balaskas, K., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.2.6 · Cited by 328

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement

Wong, N. D., Budoff, M. J., Ferdinand, K. C., Graham, I. M., Michos, E. D., Reddy, T. K., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 327

Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells

Frodermann, V., Rohde, D., Courties, G., Severe, N., Schloss, M. J., Amatullah, H., McAlpine, C. S., Cremer, S., Hoyer, F. F., Ji, F., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0633-x · Cited by 292

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

Behbodikhah, J., Ahmed, S., Elyasi, A., Kasselman, L. J., Leon, J. D., Glass, A. D., & Reiss, A. B. (2021) · Metabolites · doi:10.3390/metabo11100690 · Cited by 299

Sodium–glucose cotransporter type 2 inhibitors for the treatment of type 2 diabetes mellitus

Scheen, A. J. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0392-2 · Cited by 276

May Measurement Month 2019

Beaney, T. E., Schutte, A. E., Stergiou, G. S., Borghi, C., Burger, D. E., Charchar, F. J., Cro, S., Diaz, A., Damasceno, A. A. M., Espeche, W. G., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14874 · Cited by 269

Menopause: a cardiometabolic transition

Nappi, R. E., Chedraui, P., Lambrinoudaki, I. V., & Simoncini, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00076-6 · Cited by 283

Ferroptosis and its emerging roles in cardiovascular diseases

Li, N., Jiang, W., Wang, W., Xiong, R., Wu, X., & Geng, Q. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105466 · Cited by 256

Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists

Liu, Q. K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431292 · Cited by 265

Major Global Coronary Artery Calcium Guidelines

Golub, I. S., Termeie, O. G., Kristo, S., Schroeder, L. P., Lakshmanan, S., Shafter, A. M., Hussein, L., Verghese, D., Aldana-Bitar, J., Manubolu, V. S., et al. (2023) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2022.06.018 · Cited by 243

Sex Differences in Association of Physical Activity With All-Cause and Cardiovascular Mortality

Ji, H., Gulati, M., Huang, T. Y., Kwan, A. C., Ouyang, D., Ebinger, J. E., Casaletto, K. B., Moreau, K. L., Skali, H., & Cheng, S. C. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.019 · Cited by 242

Cardiovascular Risk in Patients With Psoriasis

Garshick, M. S., Ward, N. L., Krueger, J. G., & Berger, J. S. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.009 · Cited by 233

SGLT2i: beyond the glucose-lowering effect

Ni, L., Yuan, C., Chen, G., Zhang, C., & Wu, X. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01071-y · Cited by 240

Real‐world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP ‐ 1RA ‐based weight‐loss therapies

Thomsen, R. W., Mailhac, A., Løhde, J. B., & Pottegård, A. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16364 · Cited by 207

Diabetes mellitus and hearing loss: A review

Samocha‐Bonet, D., Wu, B., & Ryugo, D. K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101423 · Cited by 193

A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?

Diab, A., Dastmalchi, L. N., Gulati, M., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s379874 · Cited by 221

Incidental Coronary Artery Calcium: Opportunistic Screening of Previous Nongated Chest Computed Tomography Scans to Improve Statin Rates (NOTIFY-1 Project)

Sandhu, A. T., Rodriguez, F., Ngo, S., Patel, B. N., Mastrodicasa, D., Eng, D., Khandwala, N., Balla, S., Sousa, D., & Maron, D. J. (2023) · Circulation · doi:10.1161/circulationaha.122.062746 · Cited by 174

High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events

Jia, C., Anderson, J. L. C., Gruppen, E. G., Yu, L., Bakker, S. J. L., Dullaart, R. P. F., & Tietge, U. J. F. (2021) · Circulation · doi:10.1161/circulationaha.120.050808 · Cited by 179

NAFLD, and cardiovascular and cardiac diseases: Factors influencing risk, prediction and treatment

Targher, G., Corey, K. E., & Byrne, C. D. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.101215 · Cited by 174

Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses

Sun, L., Pennells, L. A. M., Kaptoge, S. K., Nelson, C. P., Abraham, G., Arnold, M., Bell, S., Bolton, T., Burgess, S., Dudbridge, F., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003498 · Cited by 172

Dyslipidemia

Arvanitis, M., & Lowenstein, C. J. (2023) · Annals of Internal Medicine · doi:10.7326/aitc202306200 · Cited by 174

Complete versus incomplete coronary revascularization: definitions, assessment and outcomes

Gaba, P., Gersh, B. J., Ali, Z. A., Moses, J. W., & Stone, G. W. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00457-5 · Cited by 167

XGBoost, A Novel Explainable AI Technique, in the Prediction of Myocardial Infarction: A UK Biobank Cohort Study

Moore, A., & Bell, M. (2022) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468221133611 · Cited by 158

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases

Liu, Y., Huang, Y., Xu, C. B., An, P., Luo, Y., Jiao, L., Luo, J., & Li, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416053 · Cited by 151

Childhood Obesity and Cardiovascular Disease Risk

Chung, S. T., Krenek, A. M., & Magge, S. N. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01111-4 · Cited by 189

Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases

Schiano, C., Benincasa, G., Franzese, M., Mura, N. D., Pane, K., Salvatore, M., & Claudio Napoli, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107514 · Cited by 136

Spectral photon-counting CT in cardiovascular imaging

Sandfort, V., Persson, M., Pourmorteza, A., Noël, P. B., Fleischmann, D., & Willemink, M. J. (2020) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2020.12.005 · Cited by 132

Improving the enrollment of women and racially/ethnically diverse populations in cardiovascular clinical trials: An ASPC practice statement

Michos, E. D., Reddy, T. K., Gulati, M., Brewer, L. C., Bond, R. M., Velarde, G., Bailey, A. L., Echols, M. R., Nasser, S. A., Bays, H. E., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100250 · Cited by 128

A Clinician's Guide to Healthy Eating for Cardiovascular Disease Prevention

Pallazola, V. A., Davis, D. M., Whelton, S. P., Cardoso, R. N., Latina, J. M., Michos, E. D., Sarkar, S., Blumenthal, R. S., Arnett, D. K., Stone, N. J., et al. (2019) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2019.05.001 · Cited by 134

The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease

Chakaroun, R., Olsson, L. M., & Bäckhed, F. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00771-0 · Cited by 131

Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

Mendieta, G., Pocock, S., Mass, V., Moreno, A. D., Owen, R., García‐Lunar, I., López‐Melgar, B., Fuster, J. J., Andrés, V., Pérez-Herreras, C., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.814 · Cited by 125

Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products

Akiyama, Y., & Sherwood, N. (2021) · Toxicology Reports · doi:10.1016/j.toxrep.2021.01.014 · Cited by 114

Cardiovascular Disease in Systemic Lupus Erythematosus: Recent Data on Epidemiology, Risk Factors and Prevention

Kostopoulou, M., Nikolopoulos, D., Parodis, I., & Bertsias, G. K. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161118666191227101636 · Cited by 114

Inflammatory Bowel Disease and Atherosclerotic Cardiovascular Disease

Cainzos‐Achirica, M., Glassner, K. L., Hassan, S. Z., Dey, A. K., Agrawal, T., Quigley, E. M. M., Abraham, B. P., Acquah, I., Yahya, T., Mehta, N. N., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.027 · Cited by 112

Emerging roles of ferroptosis in cardiovascular diseases

Wang, K., Chen, X., Wang, Y.-H., Cheng, X., Zhao, Y., Zhou, L., & Wang, K. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01183-2 · Cited by 117

Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?

Bigeh, A., Sanchez, A. M., Maestas, C. M., & Gulati, M. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.10.001 · Cited by 106

Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors

Zelniker, T. A., & Braunwald, E. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.036 · Cited by 112

The essential menopause curriculum for healthcare professionals: A European Menopause and Andropause Society (EMAS) position statement

REES, M. C. P., Abernethy, K., Bachmann, G. A., Bretz, S., Ceauşu, I., Durmuşoğlu, F., Erkkola, R., Fistonić, I., Gambacciani, M., Geukes, M., et al. (2022) · Maturitas · doi:10.1016/j.maturitas.2021.12.001 · Cited by 105

Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians

Wang, M., Menon, R., Mishra, S., Patel, A. P., Chaffin, M. D., Tanneeru, D., Deshmukh, M., Mathew, O., Apte, S., Devanboo, C. S., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.06.024 · Cited by 106

Statin Use and In‐Hospital Mortality in Patients With Diabetes Mellitus and COVID‐19

Saeed, O., Castagna, F., Agalliu, I., Xue, X., Patel, S. R., Rochlani, Y. M., Kataria, R., Vukelic, S., Sims, D. B., Alvarez, C., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018475 · Cited by 101

Tobacco use disorder and cardiovascular health

Benowitz, N. L., & Liakoni, E. (2021) · Addiction · doi:10.1111/add.15703 · Cited by 111

Clinical utility and implementation of polygenic risk scores for predicting cardiovascular disease

Schunkert, H., Angelantonio, E. D., Inouye, M., Patel, R. S., Ripatti, S., Widén, E., Sanderson, S. C., Kaski, J. P., McEvoy, J. W., Vardas, P. E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae649 · Cited by 107

Performance of polygenic risk scores in screening, prediction, and risk stratification: secondary analysis of data in the Polygenic Score Catalog

Hingorani, A. D., Gratton, J., Finan, C., Schmidt, A. F., Patel, R. S., Sofat, R., Kuan, V., Langenberg, C., Hemingway, H., Morris, J. K., et al. (2023) · BMJ Medicine · doi:10.1136/bmjmed-2023-000554 · Cited by 100

Air pollution exposure is linked with methylation of immunoregulatory genes, altered immune cell profiles, and increased blood pressure in children

Prunicki, M. M., Cauwenberghs, N., Lee, J., Zhou, X., Movassagh, H., Noth, E. M., Lurmann, F. W., Hammond, S. K., Balmes, J. R., Desai, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83577-3 · Cited by 100

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

Zhou, X., Kim, S. U., Yip, T. C., Petta, S., Nakajima, A., Tsochatzis, E. A., Boursier, J., Bugianesi, E., Hagström, H., Chan, W., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-333074 · Cited by 94

Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

Enkhmaa, B., Petersen, K. H., Kris‐Etherton, P. M., & Berglund, L. (2020) · Nutrients · doi:10.3390/nu12072024 · Cited by 98

Coronary Atherosclerosis in an Asymptomatic U.S. Population

Nasir, K., Cainzos‐Achirica, M., Elizondo, J. V., Ali, S. S., Havistin, R., Lakshman, S., Blaha, M. J., Blankstein, R., Shapiro, M. D., Arias, L., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.03.010 · Cited by 94

Nutritional Composition of Hass Avocado Pulp

Ford, N. A., Spagnuolo, P. A., Kraft, J., & Bauer, E. E. (2023) · Foods · doi:10.3390/foods12132516 · Cited by 90

GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment

Ballout, R. A., & Remaley, A. T. (2020) · Journal of Laboratory and Precision Medicine · doi:10.21037/jlpm.2020.03.03 · Cited by 89

Platelets as therapeutic targets to prevent atherosclerosis

Nording, H., Baron, L., & Langer, H. F. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.05.018 · Cited by 90

Role of Dipeptidyl Peptidase 4 Inhibitors in Antidiabetic Treatment

Yin, R., Xu, Y., Wang, X., Yang, L., & Zhao, D. (2022) · Molecules · doi:10.3390/molecules27103055 · Cited by 98

Ceramide Scores Predict Cardiovascular Risk in the Community

Vasile, V. C., Meeusen, J. W., Medina‐Inojosa, J. R., Donato, L. J., Scott, C. G., Hyun, M., Vinciguerra, M., Rodeheffer, R. R., López-Jiménez, F. A., & Jaffe, A. S. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315530 · Cited by 88

Primary Prevention of Subclinical Atherosclerosis in Young Adults

Devesa, A., Ibáñez, B., Malick, W. A., Tinuoye, E. O., Bustamante, J., Peyra, C., Rosenson, R. S., Bhatt, D. L., Stone, G. W., & Fuster, V. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.09.817 · Cited by 101

Educational attainment and cardiovascular disease in the United States: A quasi-experimental instrumental variables analysis

Hamad, R., Nguyen, T. T. X., Bhattacharya, J., Glymour, M. M., & Rehkopf, D. H. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002834 · Cited by 89

Artificial intelligence in cardiac radiology

van Assen, M., Muscogiuri, G., Caruso, D., Lee, S., Laghi, A., & Cecco, C. N. D. (2020) · La radiologia medica · doi:10.1007/s11547-020-01277-w · Cited by 90

Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools

Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319876 · Cited by 97

Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes

Tasali, E., Pamidi, S., Covassin, N., & Somers, V. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325676 · Cited by 108

Activated Platelets Induce Endothelial Cell Inflammatory Response in Psoriasis via COX-1

Garshick, M. S., Tawil, M., Barrett, T. J., Salud-Gnilo, C., Eppler, M., Lee, A., Scher, J. U., Neimann, A. L., Jelić, S., Mehta, N. N., et al. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.314008 · Cited by 83

Lipoprotein(a): Knowns, unknowns and uncertainties

Ruscica, M., Sirtori, C. R., Corsini, A., Watts, G. F., & Sahebkar, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105812 · Cited by 84

Association of Smoking Cessation and Survival Among Young Adults With Myocardial Infarction in the Partners YOUNG-MI Registry

Biery, D. W., Berman, A. N., Singh, A., Divakaran, S., DeFilippis, E. M., Collins, B., Gupta, A., Fatima, A., Qamar, A., Klein, J., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.9649 · Cited by 80

LDL-C target attainment in secondary prevention of ASCVD in the United States: barriers, consequences of nonachievement, and strategies to reach goals

Underberg, J. A., Toth, P. P., & Rodríguez, F. (2022) · Postgraduate Medicine · doi:10.1080/00325481.2022.2117498 · Cited by 81

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions

Perone, F., Bernardi, M., Redheuil, A. B., Mafrica, D., Conte, E., Spadafora, L., Ecarnot, F., Tokgözoğlu, L. S., Santos‐Gallego, C. G., Kaiser, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12175563 · Cited by 78

NAFLD and Cardiovascular Diseases: Epidemiological, Mechanistic and Therapeutic Considerations

Niederseer, D., Wernly, B., Aigner, E. S., Stickel, F., & Datz, C. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030467 · Cited by 87

Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver

Zhong, S., Li, L., Liang, N., Zhang, L., Xu, X., Chen, S., & Yin, H. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101919 · Cited by 81

Heterogeneity in statin responses explained by variation in the human gut microbiome

Wilmanski, T. M., Kornilov, S. A., Diener, C., Conomos, M. P., Lovejoy, J. C., Sebastiani, P., ORWOLL, E. S., Hood, L., Price, N. D., Rappaport, N., et al. (2022) · Med · doi:10.1016/j.medj.2022.04.007 · Cited by 76

Reducing disparities in adverse pregnancy outcomes in the United States

Shah, L. M., Varma, B., Nasir, K., Walsh, M. N., Blumenthal, R. S., Mehta, L. S., & Sharma, G. V. (2021) · American Heart Journal · doi:10.1016/j.ahj.2021.08.019 · Cited by 80

Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk

Prizment, A. E., Staley, C. M., Onyeaghala, G. C., Vivek, S., Thyagarajan, B., Straka, R. J., Demmer, R. T., Knights, D., Meyer, K. A., Shaukat, A., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16013 · Cited by 76

Psoriasis and Psoriatic Arthritis Cardiovascular Disease Endotypes Identified by Red Blood Cell Distribution Width and Mean Platelet Volume

Conic, R. R. Z., Damiani, G. B., Schrom, K. P., Ramser, A. E., Zheng, C., Xu, R., McCormick, T. S., & Cooper, K. D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010186 · Cited by 70

What Is the Best Mix of Population‐Wide and High‐Risk Targeted Strategies of Primary Stroke and Cardiovascular Disease Prevention?

Feigin, V. L., Brainin, M., Norrving, B. G., Gorelick, P. B., Dichgans, M., Wang, W., Pandian, J. D., Martins, S. C. O., Owolabi, M. O., Wood, D. A., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014494 · Cited by 73

Exercise Prescription to Foster Health and Well-Being: A Behavioral Approach to Transform Barriers into Opportunities

Lucini, D., & Pagani, M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18030968 · Cited by 75

Metabolic Associated Fatty Liver Disease Increases the Risk of Systemic Complications and Mortality. A Meta-Analysis and Systematic Review of 12 620 736 Individuals

Quek, J., Ng, C. H., Tang, A. S. P., Chew, N., Chan, M. Y., Khoo, C. M., Wei, C. P., Chin, Y. H., Tay, P. W. L., Lim, G., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.03.016 · Cited by 74

Lp(a) and Apo-lipoproteins as predictors for micro- and macrovascular complications of diabetes: A case-cohort study

Moosaie, F., Firouzabadi, F. D., Abouhamzeh, K., Esteghamati, S., Meysamie, A., Rabizadeh, S., Nakhjavani, M., & Esteghamati, A. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.05.011 · Cited by 67

Top 10 dietary strategies for atherosclerotic cardiovascular risk reduction

Sikand, G., & Severson, T. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100106 · Cited by 73

Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline

Tomson, C., Cheung, A. K., Mann, J. F. E., Chang, T. I., Cushman, W. C., Furth, S. L., Hou, F. F., Knoll, G. A., Muntner, P., Pecoits‐Filho, R., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0834 · Cited by 69

Effects of Experimental Sleep Restriction on Ambulatory and Sleep Blood Pressure in Healthy Young Adults: A Randomized Crossover Study

Covassin, N., Bukartyk, J., Singh, P., Calvin, A. D., Louis, E. K. S., & Somers, V. K. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17622 · Cited by 66

The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial

Tsaban, G., Meir, A. Y., Rinott, E., Zelicha, H., Kaplan, A., Shaleṿ, A., Katz, A., Rudich, A., Tirosh, A., Shelef, I., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317802 · Cited by 73

Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score–matched comparative study

Alqahtani, A. R., Elahmedi, M. O., Al-Darwish, A., Abdurabu, H. Y., & Alqahtani, S. (2022) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2022.02.050 · Cited by 66

Food Insecurity Among Individuals With Cardiovascular Disease and Cardiometabolic Risk Factors Across Race and Ethnicity in 1999-2018

Brandt, E. J., Chang, T., Leung, C. W., Ayanian, J. Z., & Nallamothu, B. K. (2022) · JAMA Cardiology · doi:10.1001/jamacardio.2022.3729 · Cited by 64

Differential Associations of Chronic Inflammatory Diseases With Incident Heart Failure

Prasada, S., Rivera, A. S., Nishtala, A., Pawlowski, A. E., Sinha, A., Bundy, J. D., Chadha, S. A., Ahmad, F. S., Khan, S. S., Achenbach, C. J., et al. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.11.013 · Cited by 64

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.010 · Cited by 1,896

Addendum to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary

(2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.015 · Cited by 1

Addendum to: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

(2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.03.016 · Cited by 1

2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Part 1, Lifestyle and Behavioral Factors

Arnett, D. K., Khera, A., & Blumenthal, R. S. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.2604 · Cited by 182